Related references
Note: Only part of the references are listed.Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy
S. Allison Staley et al.
GYNECOLOGIC ONCOLOGY (2020)
Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma
Se Ik Kim et al.
CANCERS (2020)
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer
Chueh-Yi Huang et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis
Jorne Ubachs et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer
Lesley B. Conrad et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis
Ioannis Mintziras et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Relationship between sarcopenic obesity-related phenotypes and inflammatory markers in postmenopausal women
Maurilio Tiradentes Dutra et al.
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2017)
Psoas as a sentinel muscle for sarcopenia: a flawed premise
Vickie E. Baracos
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer Results From the C SCANS Study
Elizabeth M. Cespedes Feliciano et al.
JAMA ONCOLOGY (2017)
Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers
Tomoyuki Yoshikawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging
Sanaz Javadi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2016)
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shlomit Strulov Shachar et al.
EUROPEAN JOURNAL OF CANCER (2016)
Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer
Amanika Kumar et al.
GYNECOLOGIC ONCOLOGY (2016)
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Neil M. Iyengar et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later
Aoife M. Ryan et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2016)
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients
Tora S. Solheim et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Share Paper
